Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

F2G

Biotech & Life Sciences · Manchester, United Kingdom · Founded 1998 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$500M–1B
Latest valuation · 2026
Unlock exact value
Revenue
$100–500M
Latest reported FY
Unlock exact value
Headcount
<100
Current team size
Unlock exact value

Investors

18 investors on F2G's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage
Merifin Capital
K Nominees
BankInvest
Astellas Venture
Series B+ 14 investors entered at this stage
Novartis Venture Fund
Intermediate Capital Group
Novo Holdings
Aisling Capital
The University of Manchester
Sofinnova Partners
Sectoral Asset Management
Heartcore Capital
Morningside
AMR Action Fund
Cowen Group
Advent Life Sciences
Forbion Capital Partners
Brace Pharma

Global footprint

Where F2G has talent and traffic

Web traffic by country
6.1K monthly visits
across markets
🇺🇸 United States39.3%
🇬🇧 United Kingdom31.1%
🇮🇳 India27.9%
Top 3 markets shown

See F2G on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo